Ariosa Diagnostics, Inc. v. Illumina, Inc.

 
DOCKET NO.
OP. BELOW
SUBJECT
Patent

Question(s) Presented

“Whether a patent that claims nothing more than a method for separating smaller DNA fragments from larger ones, and analyzing the separated DNA for diagnostic purposes, using well-known laboratory techniques is unpatentable under Section 101 and Myriad.”

Posts About this Case

Date
Proceedings and Orders
February 10, 2021
DISTRIBUTED for Conference of 2/26/2021.
February 16, 2021
Response Requested. (Due March 18, 2021)
February 22, 2021
Motion to extend the time to file a response is granted and the time is extended to and including April 19, 2021.